Sbir phase 1 new award N43DA-8-8874 titled novel azetidine CB1 antagonists

Ended Definitive Contract Awarded Last action

Contract number
HHSN271200800010C
Awardee
Awarding agency
Obligated
$119,000

Award facts

Contract value 100% obligated
$119,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Firm Fixed Price
Place of performance
West Mystic, CT 06388, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 · Novel azetidine CB1 antagonists $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $119,000

Quick answers

Who was awarded contract HHSN271200800010C?

HHSN271200800010C was awarded to Makscientific LLC by National Institute on Drug Abuse (National Institutes of Health) on April 29, 2008.

How much is contract HHSN271200800010C worth?

The government has obligated $119,000 on HHSN271200800010C.

Was contract HHSN271200800010C competed?

The extent of competition for HHSN271200800010C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award